| Total (n = 114) |
---|---|
Female : Male | 84 : 30 |
Age (mean years ± SD) | 35.0 ± 10.7 |
Age at onset (mean years ± SD) | 26.2 ± 9.0 |
Course | Â |
   relapsing-remitting type | 79 (69.3%) |
   secondary-progressive type | 35 (30.7%) |
Duration (mean years ± SD) | 8.9 ± 8.4 |
EDSS (mean ± SD) | 3.0 ± 2.5 |
HLA-DRB1*1501 allele positive | 34/107 (31.8%) |